QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
NASDAQ:SGEN

Seagen (SGEN) Competitors

$215.52
+1.82 (+0.85%)
(As of 09/25/2023 ET)
Compare
Today's Range
$213.22
$215.70
50-Day Range
$191.57
$213.70
52-Week Range
$116.08
$215.70
Volume
1.88 million shs
Average Volume
1.35 million shs
Market Capitalization
$40.45 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$190.47

SGEN vs. BIIB, NBIX, GILD, AMGN, MRNA, ARGX, BNTX, TECH, ALC, and IQV

Should you be buying Seagen stock or one of its competitors? The main competitors of Seagen include Biogen (BIIB), Neurocrine Biosciences (NBIX), Gilead Sciences (GILD), Amgen (AMGN), Moderna (MRNA), argenx (ARGX), BioNTech (BNTX), Bio-Techne (TECH), Alcon (ALC), and IQVIA (IQV). These companies are all part of the "medical" sector.

Seagen vs.

Biogen (NASDAQ:BIIB) and Seagen (NASDAQ:SGEN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, community ranking, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

In the previous week, Seagen had 6 more articles in the media than Biogen. MarketBeat recorded 20 mentions for Seagen and 14 mentions for Biogen. Seagen's average media sentiment score of 1.08 beat Biogen's score of 0.65 indicating that Biogen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biogen
9 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Seagen
7 Very Positive mention(s)
5 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Biogen has higher revenue and earnings than Seagen. Seagen is trading at a lower price-to-earnings ratio than Biogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biogen$10.17B3.63$3.05B$18.3713.88
Seagen$1.96B20.61-$610.31M-$3.89-55.40

Biogen currently has a consensus price target of $325.36, indicating a potential upside of 27.58%. Seagen has a consensus price target of $190.47, indicating a potential downside of 11.62%. Given Seagen's stronger consensus rating and higher possible upside, research analysts clearly believe Biogen is more favorable than Seagen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biogen
0 Sell rating(s)
5 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.81
Seagen
0 Sell rating(s)
11 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.35

Biogen has a net margin of 26.72% compared to Biogen's net margin of -33.54%. Seagen's return on equity of 17.33% beat Biogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Biogen26.72% 17.33% 9.51%
Seagen -33.54%-26.46%-20.24%

86.0% of Biogen shares are held by institutional investors. Comparatively, 84.3% of Seagen shares are held by institutional investors. 0.6% of Biogen shares are held by company insiders. Comparatively, 25.9% of Seagen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Biogen has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, Seagen has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500.

Biogen received 985 more outperform votes than Seagen when rated by MarketBeat users. Likewise, 72.00% of users gave Biogen an outperform vote while only 63.70% of users gave Seagen an outperform vote.

CompanyUnderperformOutperform
BiogenOutperform Votes
1736
72.00%
Underperform Votes
675
28.00%
SeagenOutperform Votes
751
63.70%
Underperform Votes
428
36.30%

Summary

Biogen beats Seagen on 14 of the 18 factors compared between the two stocks.


Get Seagen News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGEN vs. The Competition

MetricSeagenBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$40.45B$2.59B$4.40B$6.29B
Dividend YieldN/A2.25%5.85%9.76%
P/E Ratio-55.407.04140.3713.19
Price / Sales20.61141.042,850.0356.56
Price / CashN/A25.1021.6422.67
Price / Book14.273.413.814.68
Net Income-$610.31M$55.34M$122.15M$185.66M
7 Day Performance4.03%5.48%-1.16%-2.43%
1 Month Performance7.86%-6.53%-2.44%-4.45%
1 Year Performance54.83%16.14%8.83%4.87%

Seagen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIIB
Biogen
2.8325 of 5 stars
$256.67
+1.3%
$325.36
+26.8%
+30.3%$37.17B$10.17B13.978,725Positive News
NBIX
Neurocrine Biosciences
2.8047 of 5 stars
$114.80
+2.5%
$128.13
+11.6%
+9.9%$11.21B$1.49B66.361,200Analyst Upgrade
GILD
Gilead Sciences
3.6303 of 5 stars
$75.77
+0.2%
$90.05
+18.8%
+19.3%$94.41B$27.28B17.4217,000
AMGN
Amgen
3.1378 of 5 stars
$264.31
+0.4%
$265.44
+0.4%
+17.9%$141.38B$26.32B17.8225,200Positive News
MRNA
Moderna
2.5975 of 5 stars
$106.74
+2.5%
$155.52
+45.7%
-19.1%$39.63B$10.52B39.393,900Insider Selling
ARGX
argenx
1.7171 of 5 stars
$524.13
+0.2%
$506.71
-3.3%
+47.4%$30.68B$445.27M-73.10843
BNTX
BioNTech
2.3244 of 5 stars
$110.43
+1.3%
$158.69
+43.7%
-18.5%$26.61B$18.24B6.194,530
TECH
Bio-Techne
3.2323 of 5 stars
$70.63
-0.8%
$101.58
+43.8%
-4.7%$11.18B$1.14B40.073,050
ALC
Alcon
2.675 of 5 stars
$80.43
-0.9%
$89.53
+11.3%
+30.4%$39.42B$8.72B111.7125,000
IQV
IQVIA
2.9206 of 5 stars
$208.88
-0.2%
$252.00
+20.6%
+4.9%$38.25B$14.41B35.9586,000Positive News

Related Companies and Tools

This page (NASDAQ:SGEN) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -